Skip to main content
Log in

The effect of weight loss and dietary fatty acids on inflammation

  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

Abstract

Inflammation plays a pivotal role in all stages of atherosclerosis. Weight loss appears to be the best nonpharmacologic modality to reduce inflammation. Intervention trials convincingly demonstrate that weight loss reduces biomarkers of inflammation, such as C-reactive protein. Limited studies have shown that certain dietary fatty acids (ie, oleic acid and α-linolenic acid) reduce biomarkers of inflammation. Most of the studies with fish oil supplementation have shown null effects, and conflicting results have been reported with saturated and trans fatty acids. Much further research is needed to define the role of individual dietary factors on the biomarkers of inflammation and the mechanism of the anti-inflammatory effects of weight loss.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Ross R: Atherosclerosis—an inflammatory disease. N Engl J Med 1999, 340:115–126.

    Article  PubMed  CAS  Google Scholar 

  2. Libby P: Inflammation in atherosclerosis. Nature 2002, 420:868–874.

    Article  PubMed  CAS  Google Scholar 

  3. Ridker PM, Haughie P: Prospective studies of C-reactive protein as a risk factor for cardiovascular disease. J Invest Med 1998, 46:391–395.

    CAS  Google Scholar 

  4. Ridker PM: High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001, 103:1813–1818.

    PubMed  CAS  Google Scholar 

  5. Ridker PM, Buring JE, Shih J, et al.: Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998, 98:731–733.

    PubMed  CAS  Google Scholar 

  6. Ridker PM, Hennekens CH, Buring JE, Rifai N: C-Reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342:836–843.

    Article  PubMed  CAS  Google Scholar 

  7. Jialal I, Devaraj S, Venugopal SK: C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension 2004, 44:1–6.

    Article  Google Scholar 

  8. Verma S, Devaraj S, Jialal I: Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis. Circulation 2006, 113:2135–2150.

    PubMed  Google Scholar 

  9. Visser M, Bouter LM, McQuillan GM, et al.: Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999, 282:2131–2135.

    Article  PubMed  CAS  Google Scholar 

  10. Mohamed-Ali V, Goodrick S, Rawesh A, et al.: Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-a, in vivo. J Clin Endocrinol Metab 1997, 82:4196–4200.

    Article  PubMed  CAS  Google Scholar 

  11. Mohamed-Ali V, Pinkney JH, Coppack SW: Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord 1998, 22:1145–1158.

    Article  PubMed  CAS  Google Scholar 

  12. Basu A, Devaraj S, Jialal I: Dietary factors that promote or retard inflammation. Arterioscler Thromb Vasc Biol 2006, In press.

  13. Jialal I, Dietrich M: The effect of weight loss on a stable biomarker of inflammation, C-reactive protein. J Nutr 2005, 63:22–28.

    Google Scholar 

  14. Kopp HP, Kopp CW, Festa A, et al.: Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol 2003, 23:1042–1047.

    Article  PubMed  CAS  Google Scholar 

  15. Laimer M, Ebenbichler CF, Kaser S, et al.: Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention. Int J Obes 2002, 26:659–662.

    Article  CAS  Google Scholar 

  16. Hanusch-Enserer U, Cauza E, Spak M, et al.: Acute-phase response and immunological markers in morbid obese patients and patients following adjustable gastric banding. Int J Obes 2003, 27:355–361.

    Article  CAS  Google Scholar 

  17. Heilbronn LK, Noakes M, Clifton PM: Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women. Arterioscler Thromb Vasc Biol 2001, 21:968–970.

    PubMed  CAS  Google Scholar 

  18. Tchernof A, Nolan A, Sites CK, et al.: Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation 2002, 105:564–569.

    Article  PubMed  Google Scholar 

  19. Esposito K, Pontillo A, Di Palo C, et al.: Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003, 289:1799–1804.

    Article  PubMed  CAS  Google Scholar 

  20. Esposito K, Marfella R, Ciotola M, et al.: Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004, 292:1440–1446.

    Article  PubMed  CAS  Google Scholar 

  21. Bastard JP, Jardel C, Bruckert E, et al.: Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 2000, 85:3338–3342.

    Article  PubMed  CAS  Google Scholar 

  22. Seshadri P, Iqbal N, Stern L, et al.: A randomized study comparing the effects of a low-carbohydrate diet and a conventional diet on lipoprotein subfractions and C-reactive protein levels in patients with severe obesity. Am J Med 2004, 117:398–405.

    Article  PubMed  CAS  Google Scholar 

  23. Wood RJ, Volek JS, Davis SR, et al.: Effects of a carbohydrate-restricted diet on emerging plasma markers for cardiovascular disease. Nutr Metab (Lond) 2006, 3:19.

    Article  Google Scholar 

  24. Jenkins DJ, Kendall CW, Connelly PW, et al.: Effects of high- and low-isoflavone (phytoestrogen) soy foods on inflammatory biomarkers and proinflammatory cytokines in middle-aged men and women. Metabolism 2002, 51:919–924.

    Article  PubMed  CAS  Google Scholar 

  25. Balagopal P, George D, Yarandi H, et al.: Reversal of obesity-related hypoadiponectinemia by lifestyle intervention: a controlled, randomized study in obese adolescents. J Clin Endocrinol Metab 2005, 90:6192–6197.

    Article  PubMed  CAS  Google Scholar 

  26. Balagopal P, George D, Patton N, et al.: Lifestyle-only intervention attenuates the inflammatory state associated with obesity: a randomized controlled study in adolescents. J Pediatr 2005, 146:342–348.

    Article  PubMed  Google Scholar 

  27. Dvorakova-Lorenzova A, Suchanek P, Havel PJ, et al.: The decrease in C-reactive protein concentration after diet and physical activity induced weight reduction is associated with changes in plasma lipids, but not interleukin-6 or adiponectin. Metabolism 2006, 55:359–365.

    Article  PubMed  CAS  Google Scholar 

  28. Dansinger ML, Gleason JA, Griffith JL, et al.: Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA 2005, 293:43–53.

    Article  PubMed  CAS  Google Scholar 

  29. Clifton PM, Keogh JB, Foster PR, Noakes M: Effect of weight loss on inflammatory and endothelial markers and FMD using two low-fat diets. Int J Obes (Lond) 2005, 29:1445–1451.

    Article  CAS  Google Scholar 

  30. McLaughlin T, Abbasi F, Lamendola C, et al.: Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation 2002, 106:2908–2912.

    Article  PubMed  CAS  Google Scholar 

  31. Kasim-Karakas SE, Tsodikov A, Singh U, Jialal I: Responses of inflammatory markers to a low-fat, high-carbohydrate diet: effects of energy intake. Am J Clin Nutr 2006, 83:774–779.

    PubMed  CAS  Google Scholar 

  32. Fung TT, Rimm EB, Spiegelman D, Rifai N: Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. Am J Clin Nutr 2001, 73:61–67.

    PubMed  CAS  Google Scholar 

  33. King DE, Egan BM, Geesey ME: Relation of dietary fat and fiber to elevation of C-reactive protein. Am J Cardiol 2003, 92:1335–1339.

    Article  PubMed  CAS  Google Scholar 

  34. Lopez-Garcia E, Schulze MB, Fung TT, et al.: Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr 2004, 80:1029–1035.

    PubMed  CAS  Google Scholar 

  35. Mozaffarian D, Pischon T, Hankinson SE, et al.: Dietary intake of trans fatty acids and systemic inflammation in women. Am J Clin Nutr 2004, 79:606–612.

    PubMed  CAS  Google Scholar 

  36. Baer DJ, Judd JT, Clevidence BA, Tracy RP: Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr 2004, 79:969–973.

    PubMed  CAS  Google Scholar 

  37. Lichtenstein AH, Erkkila AT, Lamarche B, et al.: Influence of hydrogenated fat and butter on CVD risk factors: remnant-like particles, glucose and insulin, blood pressure and C-reactive protein. Atherosclerosis 2003, 171:97–107.

    Article  PubMed  CAS  Google Scholar 

  38. Han NS, Leka LS, Lichtenstein AH, et al.: Effect of hydrogenated and saturated, relative to polyunsaturated, fat on immune and inflammatory responses of adults with moderate hypercholesterolemia. J Lipid Res 2002, 43:445–452.

    PubMed  CAS  Google Scholar 

  39. Nappo F, Esposito K, Cioffi M, et al.: Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J Am Coll Cardiol 2002, 39:1145–1150.

    Article  PubMed  CAS  Google Scholar 

  40. de Lorgeril M, Salen P, Martin JL, et al.: Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999, 99:779–785.

    PubMed  Google Scholar 

  41. Michalsen A, Lehmann N, Pithan C, et al.: Mediterranean diet has no effect on markers of inflammation and metabolic risk factors in patients with coronary artery disease. Eur J Clin Nutr 2005, 23:1–8.

    Google Scholar 

  42. Desroches S, Archer WR, Paradis ME, et al.: Baseline plasma C-reactive protein concentrations influence lipid and lipoprotein responses to low-fat and high monounsaturated fatty acid diets in healthy men. J Nutr 2006, 136:1005–1011.

    PubMed  CAS  Google Scholar 

  43. Dolecek TA: Epidemiological evidence of relationships between dietary polyunsaturated fatty acids and mortality in the multiple risk factor intervention trial. Proc Soc Exp Biol Med 1992, 200:177–182.

    PubMed  CAS  Google Scholar 

  44. Hu FB, Stampfer MJ, Manson JE, et al.: Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women. Am J Clin Nutr 1999, 69:890–897.

    PubMed  CAS  Google Scholar 

  45. Rallidis LS, Paschos G, Liakos GK, et al.: Dietary alpha-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Atherosclerosis 2003, 167:237–242.

    Article  PubMed  CAS  Google Scholar 

  46. Bemelmans WJ, Lefrandt JD, Feskens EJ, et al.: Increased alpha-linolenic acid intake lowers C-reactive protein, but has no effect on markers of atherosclerosis. Eur J Clin Nutr 2004, 58:1083–1089.

    Article  PubMed  CAS  Google Scholar 

  47. Zhao G, Etherton TD, Martin KR, et al.: Dietary alpha-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J Nutr 2004, 134:2991–2997.

    PubMed  CAS  Google Scholar 

  48. Simopoulos AP: Essential fatty acids in health and chronic disease. Am J Clin Nutr 1999, 70:560S-569S.

    PubMed  CAS  Google Scholar 

  49. Lopez-Garcia E, Schulze MB, Manson JE, et al.: Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 2004, 134:1806–1811.

    PubMed  CAS  Google Scholar 

  50. Madsen T, Skou HA, Hansen VE, et al.: C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease. Am J Cardiol 2001, 88:1139–1142.

    Article  PubMed  CAS  Google Scholar 

  51. Chan DC, Watts GF, Barrett PH, et al.: Effect of atorvastatin and fish oil on plasma high-sensitivity C-reactive protein concentrations in individuals with visceral obesity. Clin Chem 2002, 48:877–883.

    PubMed  CAS  Google Scholar 

  52. Vega-Lopez S, Kaul N, Devaraj S, et al.: Supplementation with omega3 polyunsaturated fatty acids and all-rac alpha-tocopherol alone and in combination failed to exert an anti-inflammatory effect in human volunteers. Metabolism 2004, 53:236–240.

    Article  PubMed  CAS  Google Scholar 

  53. Jellema A, Plat J, Mensink RP: Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obsse men during the fasting and postprandial state. Eur J Clin Invest 2004, 34:766–773.

    Article  PubMed  CAS  Google Scholar 

  54. Mori TA, Woodman RJ, Burke V, et al.: Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free Radic Biol Med 2003, 35:772–781.

    Article  PubMed  CAS  Google Scholar 

  55. Geelen A, Brouwer IA, Schouten EG, et al.: Intake of n-3 fatty acids from fish does not lower serum concentrations of C-reactive protein in healthy subjects. Eur J Clin Nutr 2004, 58:1440–1442.

    Article  PubMed  CAS  Google Scholar 

  56. Ciubotaru I, Lee YS, Wander RC: Dietary fish oil decreases C-reactive protein, interleukin-6, and triacylglycerol to HDL-cholesterol ratio in postmenopausal women on HRT. J Nutr Biochem 2003, 14:513–521.

    Article  PubMed  CAS  Google Scholar 

  57. Pawlosky RJ, Hibbeln JR, Lin Y, et al.: Effects of beef- and fish-based diets on the kinetics of n-3 fatty acid metabolism in human subjects. Am J Clin Nutr 2003, 77:565–572.

    PubMed  CAS  Google Scholar 

  58. Ferrucci L, Cherubini A, Bandinelli S, et al.: Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab 2006, 91:439–446.

    Article  PubMed  CAS  Google Scholar 

  59. Krebs JD, Browning LM, McLean NK, et al.: Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women. Int J Obes (Lond) 2006, In press.

  60. Smedman A, Basu S, Jovinge S, et al.: Conjugated linoleic acid increased C-reactive protein in human subjects. Br J Nutr 2005, 94:791–795.

    Article  PubMed  CAS  Google Scholar 

  61. Riserus U, Basu S, Jovinge S, et al.: Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance. Circulation 2002, 106:1925–1929.

    Article  PubMed  CAS  Google Scholar 

  62. Moloney F, Yeow TP, Mullen A, et al.: Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. Am J Clin Nutr 2004, 80:887–895.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ishwarlal Jialal MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Devaraj, S., Kasim-Karakas, S. & Jialal, I. The effect of weight loss and dietary fatty acids on inflammation. Curr Atheroscler Rep 8, 477–486 (2006). https://doi.org/10.1007/s11883-006-0023-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11883-006-0023-y

Keywords

Navigation